BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Children’s Hospital of Philadelphia Researchers Develop Cell Atlas to Uncover Significant Shifts in the Neuroblastoma Tumor Microenvironment

  April 14, 2025

   · 

  5 min read
• Press Releases

  Auna Announces Reporting Dates for First Quarter 2025 Financial Results

  April 14, 2025

   · 

  1 min read
• Press Releases

  Neural Therapeutics Strengthens IP Portfolio With a Patent Application

  Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline Doses Extraction Technology Delivering Higher Yields and Greater Purity Frankfurt Stock Exchange Ticker Symbol Changed to “HANF” Extension of LOI with CWE European Holdings (dba Hanf.com)

  April 14, 2025

   · 

  7 min read
• Press Releases

  VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma

  April 14, 2025

   · 

  6 min read
• Press Releases

  Sumitomo Pharma America enters into a Cooperative Research and Development Agreement with the National Cancer Institute to Advance Clinical Understanding of Enzomenib

  April 14, 2025

   · 

  5 min read
• Press Releases

  Kedrion Biopharma closes 2024 with a growth of +10% and unveils its new identity

  April 14, 2025

   · 

  6 min read
• Press Releases

  Pheast Therapeutics Announces First Patient Treated in Phase 1 Clinical Trial of PHST001 for Patients with Advanced Solid Tumors

  April 14, 2025

   · 

  3 min read
• Press Releases

  Consumers Taking GLP-1s for Weight Loss, Current or Discontinued, Drive Lasting Changes in Retail, Per New Acosta Group Study

  April 14, 2025

   · 

  5 min read
• Press Releases

  Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025

  April 14, 2025

   · 

  3 min read
• Press Releases

  Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial

  April 14, 2025

   · 

  15 min read